NCT01628640View on ClinicalTrials.gov

Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 3, 2012

Primary Completion Date

April 19, 2019

Study Completion Date

April 19, 2019

Conditions
Advanced Malignant Solid NeoplasmHepatocellular Carcinoma
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Pharmacological Study

Correlative studies

BIOLOGICAL

Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta

Given intratumorally

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER